An excellent concept of divergence was shown in the charts of GLENMARK Pharma when a revisit of September 2018 heights happened in the first week of January 2019 but then it happened with a decrease in the momentum in the move and hence it was imminent on the RSI.
A double top and a divergent RSI were perfect indicators to show that the move in GLENMARK would halt temporarily. Has been agood short since then. Might be able to give a couple of percent more.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.